High level of circulating human tissue kallikrein induces hypotension in a transgenic mouse model

Clinical and Experimental Hypertension

Volumn 18, Issue 8, 1996, Pages 975-993

  Song, Qing ^a   Chao, Julie ^a   Chao, Lee ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

albumin promoter; aprotinin; Hoe 140; human tissue kallikrein; hypotension; transgenic mice

Indexed keywords

APROTININ; BRADYKININ ANTAGONIST; ICATIBANT; KALLIKREIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HYPOTENSION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE LEVEL; TRANSGENIC MOUSE;

EID: 0029838236     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969609081030     Document Type: Article

References (34)

1. Margolius, H. S. Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic diseases. Annu. Rev. Pharmacol. Toxicol. 1989; 29: 343-364.
2. Muller-Esterl, W., Kininogens, kinins and kinships. Thromb. Haemost. 1989; 61: 2-6.
3. Bhoola, D. K., Figueroa, C. D., and Worthy, K. Bioregulation of kinins: kininogens, and kininases. Pharmacol. Rev. 1992; 44: 1-80.
4. Elliot, R., and Nuzum, F. R. Urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension. Endocrinology 1934; 18: 462-474.
5. Carretero, O. A., and Scicli, A. G. The renal kallikrein-kinin system in human and experimental essential hypertension. Clin. Wochenschr. 1971; 56: 113-125.
6. Margolius, H. S., Geller, R. G., Pisano, J. J., and Sjoerdsma, A. Altered urinary kallikrein excretion in human hypertension. Lancet 1971; 2: 1063-1065.
7. Margolius, H. S., Horwitz, D., Pisano, J. J., and Keiser, H. R. Urinary kallikrein in hypertension: relationship to sodium intake and sodium-retaining steroid. Circ. Res. 1974: 35: 820-825.
8. Carretero, O. A., Polomski, C., Hampton, A., and Scicli, A. G. Urinary kallikrein, plasma renin and aldosterone in New Zealand genetically hypertensive (GH) rats. Clin, Exp. Pharmacol. Physiol. 1976; 3: 55-59.
9. Carretero, O. A., Amin, V. M., Ocholik, T., Scicli, A. G., and Koch, J. Urinary kallikrein in rats bred for their susceptibility and resistance to the hypertensive effect of salt. Circ. Res. 1978; 42: 727-731.
10. Ader, J. L., Tran-Van, T., and Praddaude, F. Low urinary excretion of active and total kallikrein in young spontaneously hypertensive rats and effect of longterm angiotensin converting enzyme inhibition. J. Hypertens. 1986; 4: 151-153.
11. Ader, J. L., Tran-Van, T., and Praddaude, F. Renal tissue kallikrein in newborn and young SHR. Am. J. Hypertens. 1987; 1: 53S-55S.
12. Berry, T. D., Hasstedt, S. J., Hunt, S. C., Wu, L. L., Smith, J. B., Ash, O., Kuida, H., and Williams, R. R. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 1989; 13: 3-8.
13. Woodley-Miller, C. M., Chao, J., and Chao, L. Restriction fragment length polymorphisms mapped in spontaneously hypertensive rats using kallikrein probes. J. Hypertens. 1989; 7, 865-871.
14. Pravenec, M., Ken, V., Kunes, J., Scicli, A. G., Carretero, O. A., Simonet, L., and Kurtz, T. W. Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension 1991; 17: 242-246.
15. Wang, J., Xiong, W., Yang, Z., Davis, T., Dewey, M. J., Chao, J., and Chao, L. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 1994; 23: 236-43.
16. Pinkert, C. A., Ornitz, D. M., Brinster, R. L., and Palmiter, R. D. An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev. 1987; 1: 268-76.
17. Bieberich, C. J., Utset, M. F., Awgulewitsch, A., and Ruddle, F. H. Evidence for positive and negative regulation of the Hox-3.1 gene. Proc. Natl. Acad. Sci. USA 1990; 87: 8462-6.
18. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989, p. 7. 19-7.22.
19. Wang, C., Chao, L., and Chao, J. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats. J. Clin. Invest. 1995; 95: 1710-6.
20. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951; 193: 265-275.
21. Herbst, R. S., Friedman, N., Darnell, J. E. Jr, and Babiss, L. E. Positive and negative regulatory elements in the mouse albumin enhancer. Proc. Natl. Acad. Sci. USA 1989; 86: 1553-7.
22. Shimamoto, K., Mayfield, R. K., Margolius, H. S., Chao, J., Stroud, W., and Kaplan, A. P. Immunoreactive tissue kallikrein in human serum. J. Lab. Clin. Med. 1984; 103: 731-738.
23. Powell, D. J., Friedman, J. M., Oulette, A. J., Krauter, K. S., and Darnell, J. E. Jr. Transcriptional and post-transcriptional control of specific messenger RNAs in adult and embryonic liver. J. Mol. Biol. 1984; 179: 21-35.
24. Liu, J. K., Bergman, Y., and Zaret, K. S. The mouse albumin promoter and a distal upstream site are simultaneously DNase I hypersensitive in liver chromatin and bind similar Iiver-abundant factors in vitro. Genes Dev. 1988; 2: 528-41.
25. Geiger, R., Fink, E., Lottspeich, F., Henschen, A., and Fritz, H. Human urinary kallikrein-biochemistry and physiological studies. Fresenius Z. Anal. Chem. 1980; 301: 172-173.
26. Chen, Z., and Bode, W. Refined 2.5 A X-ray crystal structure of the complex formed by porcine kallikrein A and the bovine pancreatic trypsin inhibitor. Crystallization, Patterson search, structure determination, refinement, structure and comparison with its components and with the bovine trypsinpancreatic trypsin inhibitor complex. J. Mol. Biol. 1983; 164: 283-311.
27. Hock, F. J., Wirth, K., Albus, U., Linz, W., Gerhards, H. J., Wiemer, G., Henke, S., Breipohl, G., Konig, W., Knolle, J., and Scholkens, B. A. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol. 1991; 102: 769-73.
28. Chao, J., and Chao, L. Biochemistry, regulation and potential function of kallistatin. Biol. Chem. Hoppe-Seyler 1995; 376 (12): 705-713.
29. Figueroa, C. D., MacIver, A. G., and Bhoola, K. D. Identification of a tissue kallikrein in human polymorphonuclear leucocytes. Br. J. Haematol. 1989; 72: 321-8.
30. Roblero, J., Croxatto, H., Garcia, R., Corthorn, J., de Vito, E. Kallikrein like activity in perfusates and urine of isolated rat kidneys. Am. J. Physiol. 1976; 231: 1383-9.
31. Chen, L. M., Song, Q., Chao, L., and Chao, J. Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney. Kidney Int. 1995; 48: 690-697.
32. 2 receptor in rat kidney by anti-peptide and anti-ligand antibodies. J. Histochem. Cytochem. 1995; 43 (2): 137-148.
33. 2 receptor mRNAs in human kidney. Am. J. physiol. 1996; in press.
34. Anderson, W. F. Gene therapy. Sci. Am. 1995; 273 (3): 124.